
GlaxoSmithKline PLC — Investor Relations & Filings
GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Director/PDMR Shareholding | 2026-05-14 | English | |
| DIRECTOR/PDMR SHAREHOLDING | 2026-05-14 | English | |
| 6-K - GSK plc (0001131399) (Filer) | 2026-05-11 | English | |
| Director/PDMR Shareholding | 2026-05-11 | English | |
| 6-K - GSK plc (0001131399) (Filer) | 2026-05-11 | English | |
| 6-K - GSK plc (0001131399) (Filer) | 2026-05-11 | English |
Browse filings by year
18 years- 2026 229 filings
- 2025 709 filings
- 2024 332 filings
- 2023 304 filings
- 2022 416 filings
- 2021 350 filings
- 2020 337 filings
- 2019 337 filings
- 2018 352 filings
- 2017 355 filings
- 2016 527 filings
- 2015 397 filings
- 2014 569 filings
- 2013 727 filings
- 2012 472 filings
- 2011 400 filings
- 2010 157 filings
- 2009 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46076171 | Director/PDMR Shareholding | 2026-05-14 | English | ||
| 46121103 | DIRECTOR/PDMR SHAREHOLDING | 2026-05-14 | English | ||
| 44972608 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-11 | English | ||
| 44972657 | Director/PDMR Shareholding | 2026-05-11 | English | ||
| 44939225 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-11 | English | ||
| 44937480 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-11 | English | ||
| 44894099 | Collaboration with CTTQ for bepirovirsen | 2026-05-11 | English | ||
| 44893790 | GSK - final tranche of share buyback programme | 2026-05-11 | English | ||
| 43058845 | 2026 AGM Resolutions | 2026-05-07 | English | ||
| 41940869 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-06 | English | ||
| 41943261 | Result of AGM | 2026-05-06 | English | ||
| 41452165 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-05 | English | ||
| 41417898 | Director/PDMR Shareholding | 2026-05-05 | English | ||
| 39541834 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-01 | English | ||
| 39539231 | 6-K - GSK plc (0001131399) (Filer) | 2026-05-01 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for GlaxoSmithKline PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
GlaxoSmithKline PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5262/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5262 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5262 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5262 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5262}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GlaxoSmithKline PLC (id: 5262)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.